Compounds > 2,3-bis(4-hydroxyphenyl)-propionitrile
Page last updated: 2024-08-26

2,3-bis(4-hydroxyphenyl)-propionitrile and Breast Neoplasms

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Breast Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Bolton, JL; Chen, SN; Dietz, BM; Dong, H; Ellis, SG; Hajirahimkhan, A; Lankin, DC; Mbachu, O; Nikolic, D; Pauli, GF; Simmler, C; van Breemen, RB1
Chen, JZ; Khan, MZI; Nazli, A; Uzair, M1
Aramaki, H; Furuta, E; Kohro-Ikeda, E; Matsumoto, M; Matsuo, S; Okazaki, H; Takeda, S1
Ferguson, PL; Ralston-Hooper, KJ; Sabo-Attwood, T; Smith, LC1
Gustafsson, JA; Murk, AJ; Rietjens, I; Sotoca, AM; Ström, A; van den Berg, H; van der Saag, P; Vervoort, J1
Bolado, J; Cerliani, JP; do Campo, P; Giulianelli, S; Gorostiaga, MA; Lanari, C; Molinolo, A; Soldati, R; Vanzulli, SI; Vollmer, G; Wargon, V1
Ganapathy, M; Kirma, NB; Nair, HB; Tekmal, RR; Vadlamudi, RK1

Reviews

1 review(s) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Breast Neoplasms

ArticleYear
An overview on Estrogen receptors signaling and its ligands in breast cancer.
    European journal of medicinal chemistry, 2022, Nov-05, Volume: 241

    Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen

2022

Other Studies

6 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Breast Neoplasms

ArticleYear
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.
    Journal of natural products, 2018, 04-27, Volume: 81, Issue:4

    Topics: Breast Neoplasms; Chalcones; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Flavones; Glycyrrhiza; Humans; Plant Extracts

2018
Inhibitory modulation of human estrogen receptor α and β activities by dicyclohexyl phthalate in human breast cancer cell lines.
    The Journal of toxicological sciences, 2017, Volume: 42, Issue:4

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Endocrine Disruptors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Humans; MCF-7 Cells; Nitriles; Phthalic Acids; Propionates; Signal Transduction

2017
The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic Signatures.
    Toxicological sciences : an official journal of the Society of Toxicology, 2016, Volume: 151, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Benzhydryl Compounds; Breast Neoplasms; Cell Proliferation; Chromatography, High Pressure Liquid; Cyclopentanes; Dose-Response Relationship, Drug; Estradiol; Genistein; Humans; MCF-7 Cells; Nitriles; Phenols; Phosphoproteins; Propionates; Proteomics; Pyrazoles; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Tandem Mass Spectrometry; Time Factors

2016
Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 105, Issue:2

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fluorometry; Genes, Reporter; Green Fluorescent Proteins; Humans; Nitriles; Phenols; Propionates; Pyrazoles; RNA, Messenger; Selective Estrogen Receptor Modulators; Transfection

2008
Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
    Breast cancer research and treatment, 2010, Volume: 123, Issue:3

    Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; bcl-X Protein; Breast Neoplasms; Caspase 9; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Mice; Mice, Inbred BALB C; Nitriles; Phenols; Pyrazoles; Receptors, Progesterone; Time Factors; Tumor Burden; Tumor Cells, Cultured

2010
Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy.
    Steroids, 2011, Volume: 76, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cell Cycle Proteins; Drug Resistance, Neoplasm; Estrogen Receptor beta; Female; Humans; Letrozole; Mice; Mice, Nude; Nitriles; Triazoles; Xenograft Model Antitumor Assays

2011